Activity
Mon
Wed
Fri
Sun
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
What is this?
Less
More

Owned by Anthony

Where science meets results. Learn peptides, training, recovery & more. No ego, no fluff—just smarter bodies, better minds, built to adapt.

433 contributions to Castore: Built to Adapt
SS-31 (elamipretide) + PQQ + CoQ10 + NR/NMN Protocol
@Anthony Castore Recently saw something on SS-31 protocol and adding oral PQQ, CoQ10, plus oral NAD+ precursors so thought would share and why adding these oral supplements in addition might be beneficial. I'd like to hear thoughts of others. Combining SS-31, CoQ10, and PQQ creates a powerful triple-action synergy for a full-spectrum mitochondrial reset. When you stack them, they address three distinct pillars of cellular health simultaneously: structural protection, energetic fuel, and system expansion. The multi-layered synergy works through a step-by-step process inside the cells: Before your cells can efficiently build or fuel energy, they need stable scaffolding. - SS-31 targets the inner mitochondrial membrane and binds to cardiolipin. - By stabilizing this membrane, SS-31 physically repairs the "factory floor". - This structural optimization ensures that the electron transport chain is perfectly aligned, creating an optimal environment for CoQ10 and PQQ to do their jobs. With the factory stabilized by SS-31, CoQ10 can work at maximum efficiency. - CoQ10 shuttles the electrons through the newly stabilized membrane to generate ATP. - Crucially, PQQ directly regenerates used CoQ10 back into its active antioxidant form (ubiquinol). This creates a direct chemical loop: PQQ recycles CoQ10, keeping the electron delivery system running continuously without burning out. While SS-31 repairs existing structures and CoQ10 fuels them, PQQ ensures you don't run out of capacity. - PQQ triggers the master switch (PGC-1α) to replicate mitochondrial DNA and generate brand-new organelles. - As PQQ creates these new mitochondria, SS-31 is available to properly structure their inner membranes, and CoQ10 is waiting to fuel their electron transport chains right from the start. Instead of just increasing energy output (CoQ10) or just building new cells (PQQ), adding SS-31 ensures that your existing and newly created mitochondria are physically healthy, structurally sound, and protected against oxidative stress. Longevity researchers and advanced biohackers often refer to this trio as a comprehensive "mitochondrial longevity stack.
0 likes • 11h
There’s a reasonable rationale for combining some of these, but I’d separate complementary biology from demonstrated synergy. “Full-spectrum mitochondrial reset” gets ahead of what we can establish. I didn’t find a controlled human study testing this complete combination. The question I’d start with is, what is actually limiting energy production? Adding more components helps most when those components address a real limitation. SS-31 is the strongest part of the structural argument. It interacts with cardiolipin, a lipid in the inner mitochondrial membrane that helps organize energy-producing machinery. Experimental work shows that it can protect the cardiolipin–cytochrome c interaction and support electron transfer. But “physically repairs the factory floor” and “perfectly aligns the electron transport chain” imply a completeness we haven’t demonstrated. The human endpoints matter here too. One small randomized study in older adults found an acute improvement in one measure of mitochondrial energetic capacity, without improved fatigue resistance. A larger trial in primary mitochondrial myopathy did not meet its primary walking-distance or fatigue endpoints. Those findings don’t erase the mechanism; they show why mechanism and meaningful benefit need separate evaluation. CoQ10 is an electron carrier, rather than fuel. It accepts electrons from Complex I, Complex II, and other entry points, then transfers them toward Complex III. Both ubiquinone and ubiquinol are functional parts of that cycle. Oxidized CoQ10 isn’t “used up”; accepting and releasing electrons is its job. That’s why I’d revisit the claim that PQQ directly regenerates CoQ10 and keeps the system running continuously. PQQ has interesting redox chemistry, but I couldn’t verify that specific recycling loop as an established effect of oral supplementation in human mitochondria. And swallowing more CoQ10 doesn’t guarantee more reaches the relevant tissue. A recent randomized trial in older adults increased plasma CoQ10 without increasing muscle mitochondrial CoQ10 or improving mitochondrial function. That’s one population and exposure, but it’s an important delivery limitation.
MotC with a GHRH/GHRP
MotC with a GHRH/GHRP. Be useful or beneficial since it impairs some regenerative functions ? tissue repair is not simply a matter of maximizing AMPK or mTOR activity. Different cells require different balances of energy conservation, proliferation, inflammation and matrix remodeling. From the studies I have read , it has been shown some regenerative functions were impaired despite metabolic signaling changes. The study I am referencing too : https://pubmed.ncbi.nlm.nih.gov/42324588/
1 like • 11h
I think there’s a reasonable hypothesis for combining MOTS-c with a GHRH/GHRP, but I’d be careful about using this paper to argue either for or against it. The first thing I’d revisit is what they actually tested, human fat-derived stromal cells exposed to one concentration of MOTS-c for 48 hours, then transplanted into mice with kidney injury. That’s a pretty specific experiment to translate into “MOTS-c impairs regeneration.” The endpoints matter too. They found unfavorable effects on some repair measures, but some oxygenation findings were favorable. Blood flow, oxygenation, fibrosis, and tissue injury each tell us something different. We need to keep those findings separate. I’d also want to inspect the direct comparisons. If untreated cells significantly improve an endpoint versus control and treated cells don’t, that alone doesn’t prove the treatment impaired repair. The two treatment groups need to differ directly. With six donors and six mice per group, I’d want replication, different concentrations, and different exposure durations before making a broad claim. Increased p16/p21 expression raises a question about senescence, but doesn’t establish permanent loss of repair capacity. And the study didn’t demonstrate that AMPK caused the unfavorable effects. A GHRH/GHRP can increase GH release, and GH has evidence for increasing collagen synthesis. That makes complementary effects plausible. It doesn’t establish that adding a growth signal corrects the cellular changes seen here. My take is that this study raises a useful question about exposure and cellular context. It doesn’t settle whether systemic MOTS-c compromises human tissue repair, and it doesn’t tell us whether this combination helps. I’d keep the combination as a hypothesis and judge it by actual tissue function rather than assuming the signaling balances itself out.
ATX-304 vs. MOTS-c: The pathway matters. The person matters more.
Two people walk into a consultation and tell me the same thing.“My energy is terrible.” The first has elevated glucose, excess body fat and evidence of insulin resistance. There is plenty of stored energy, but regulating and using that fuel may be part of the problem. The second is lean, training hard, sleeping five hours a night and cutting calories because they want to get leaner. Same complaint. Very different circumstances. If I hear “low energy” and immediately reach for an AMPK activator, I’ve skipped the part that determines whether my reasoning makes sense. What is actually limiting this person? That’s the conversation I want to have about ATX-304 and MOTS-c. Both connect to AMPK, but they reach it differently. Understanding those differences gets us much further than deciding which one sounds more powerful. Let’s begin with the cell’s energy conversation. ATP is the cell’s immediately usable energy currency. When ATP is spent, ADP and AMP help communicate changes in energy availability. AMPK helps respond to that information. It can adjust fuel handling and shift the balance between processes that consume energy and those that help restore it. Think about what you do when expenses rise faster than income. You look for ways to bring more in and become more selective about where it goes. Cells do something similar. But AMPK is not one simple on/off button. It’s a three-part complex. The alpha subunit does the catalytic work. The gamma subunit helps sense energy status by binding molecules such as AMP, ADP and ATP. The beta subunit helps hold the complex together and contributes to its regulation. For this comparison, remember two things: an energy-sensing component and an activating phosphate on the working component. That phosphate sits at a site called Thr172. That’s simply the threonine building block at position 172 on AMPK’s alpha subunit. Think of the phosphate as a tag attached at that location. Now we can see where the two compounds differ. ATX-304 helps preserve an active instruction.
0 likes • 2d
The part I’d revisit first is the six hours. There’s newer stuff showing nearly a four-day half-life for ATX-304. So yesterday’s dose is still very much part of today’s conversation. That doesn’t mean AMPK stays equally elevated for four days or that muscle growth gets put on hold. Half-life tells us how slowly the body clears the drug. How strongly it affects a pathway, in which tissue, and for how long are separate questions. The small human study reporting that half-life used daily dosing in people with obesity and prediabetes. Levels accumulated over approximately three weeks, with relatively little fluctuation between doses. That makes it difficult to argue that moving it a few hours away from training creates a clean separation. On the AMPK–mTOR side, you need both working together to adapt. AMPK helps coordinate fuel availability and energy use. mTOR, particularly the group of proteins called mTORC1, helps coordinate building new proteins when the conditions support it. Building muscle costs energy. AMPK helps the cell match what it spends with what it can supply. When energy stress is substantial, AMPK can apply brakes to mTORC1 through regulatory proteins called TSC2 and raptor. But how much braking occurs depends on the strength and duration of the signal, the tissue, and the resources available. We have human research where interval cycling increased AMPK activity, yet the muscle retained its mTORC1-related response to lifting afterward. That doesn’t establish that prolonged drug exposure behaves the same way. It does show why “AMPK went up, so growth shut down” skips several steps. With ATX, early experiments showed that it helps preserve a chemical tag that keeps AMPK active. That supports a sustained signal, but we still don’t know precisely how that translates into muscle protein synthesis in trained humans. The uncoupling adds another piece. Your mitochondria use energy from food to push positively charged particles called protons across a membrane. When those protons flow back through ATP synthase, that machinery makes ATP, the energy molecule your cells spend to do their work. I would think about water held behind a dam and getting directed through a turbine. With uncoupling, some water takes a route around the turbine. Some energy gets released as heat, and the mitochondria may process more fuel and consume more oxygen to maintain ATP production.
How much is guessing costing you?
You’re putting in the work. You’re investing in your training, nutrition and supplements. You’ve listened to the podcasts and read the explanations. But when progress stalls, you still find yourself wondering what to change. And if you coach people, that question carries even more weight. Someone is trusting you with their time, money and goals. They want to know why something isn’t working and what to do next. Imagine being able to walk through that conversation with a clearer understanding of what you’re looking for. You can explain the signal their training is sending, whether their nutrition supports that demand, and what their recovery is telling you. You can identify what deserves attention before adding another tool. You know what to watch and what would make you change direction. That’s the kind of thinking we’ll develop in the Pyramid. I built this six-week course for strength coaches and people who want to understand their own health and performance well enough to make better decisions. The Pyramid gives us an order to work through. We start with the environment the body is working in, then consider the adaptation we’re asking it to make, the resources needed to support it, and the tools that might help. Once you understand how those pieces fit together, the next step becomes easier to explain. For a coach, that knowledge has value every time a client asks a question, hits a plateau or arrives with a new supplement they saw online. You can spend less time chasing disconnected answers and more time working through a plan you can explain and evaluate. That’s how you build the trust that supports long-term client relationships, referrals and a stronger business. For your own health, the value is personal. You can make more deliberate choices about where your effort and money go, recognize when you’re adding complexity without a clear purpose, and understand what progress should look like. Here’s how we’ll build that understanding. Weeks 1–2: Understand the foundation
How much is guessing costing you?
FOX 04-DRI same day as GHRH/GHRPS
@Anthony Castore thouhjts on taking Fox 04 dri same day as GHRH/GHRP .. couple hours apart ??? Is there any sense to that or is better to just wait till I’m done with GHRH/GHRP before getting into Fox 04 dri … thanks As always for you input and anyone else 🙏
0 likes • 7d
Personally, I would not combine them on the same day, and I wouldn’t assume a couple of hours apart solves the concern. Let’s walk through what each one is asking your cells to do. GHRH and GHRPs encourage your pituitary the small gland beneath your brain to release growth hormone. Growth hormone can then increase IGF-1, another messenger that helps support growth and tissue maintenance. Think of this as a message being passed along, stimulate growth hormone, increase IGF-1, then deliver instructions to responsive cells. The strength and duration of that message depend on the compounds and how they’re used. Inside the cell, IGF-1 can activate a signaling chain called PI3K–AKT. You don’t need to memorize those letters. What matters here is that this chain can strengthen the cell’s “keep functioning and stay alive” instructions. Now we need to introduce p53. Think of p53 as part of the cell’s damage-inspection system. When something goes wrong, it helps coordinate the response. It will pause division, attempt repairs, or, under the right conditions, activate programmed cell death. ( apoptosis). It’s a controlled dismantling of the cell. One way AKT supports survival is through a protein called MDM2. MDM2 acts like a brake on p53, helping control how much p53 is available and how strongly it can act. In experimental studies, activating AKT can strengthen that brake. That is one connection between growth-factor signaling and a cell’s ability to resist death. FOXO4-DRI approaches the situation from another direction. FOXO4 is a protein your cells naturally make. In certain senescent cells—cells that have stopped dividing but remain alive, sometimes contributing to tissue dysfunction FOXO4 binds to p53 and helps prevent the cell from undergoing apoptosis. FOXO4-DRI was designed to interrupt that interaction. In the models studied, this allows active p53 to move out of the nucleus, the compartment holding the cell’s genetic instructions, and helps activate the machinery that dismantles the cell. The intended outcome is removal of susceptible senescent cells.
1-10 of 433
Anthony Castore
7
2,428 points to level up
@anthony-castore-4271
Anthony Castore — SSRP Fellow & strength coach blending peptides, training, and cellular medicine to optimize performance and recovery.

Active 7m ago
Joined Jul 31, 2025
Powell, OH
Powered by